RENATO FALCI JUNIOR

Índice h a partir de 2011
3
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico

Filtros

Limpar filtros

Configurações

Resultados de Busca

Agora exibindo 1 - 10 de 28
  • conferenceObject
    Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation
    (2015) ANDRADE, H.; NAHAS, W.; KATO, R.; YAMACAKE, K.; KANASHIRO, H.; ANTONOPOULOS, I.; BULL, A.; FALCI, R.; PIOVESAN, A.
  • conferenceObject
    KIDNEY TRANSPLANT IN PATIENTS UNDER WARFARIN USE: DOES IT INCREASE THE RISKS? ANALYSIS OF OUTCOMES AND COMPLICATIONS
    (2020) BERNARDES, Felipe; SIQUEIRA, Matheus; EBAID, Gustavo; MESSI, Gustavo; FALCI, Renato; YAMACAKE, Kleiton; LOCALI, Rafael; NAHAS, William; PIOVESAN, Affonso
  • bookPart
    Cólica Nefrética
    (2013) JúNIOR, Renato Falci; SROUGI, Miguel
  • conferenceObject
    HIGH INCIDENCE OF BLADDER CARCINOMA IN RENAL-TRANSPLANTED PATIENTS WITH BLADDER AUGMENTATION: LONG-TERM CAREFUL ATTENTION IS DEMANDING
    (2018) YAMACAKE, Kleiton; BARONE, Hugo; ILARIO, Eder; MELLO, Marcos; HAIDAR, Ricardo; FALCI JUNIOR, Renato; EBAID, Gustavo; KANASHIRO, Hideki; NAHAS, William; PIOVESAN, Affonso
  • conferenceObject
    Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation.
    (2014) ANDRADE, H.; PALUELLO, D.; BATAGELLO, C.; BULL, A.; EBAID, G.; KANASHIRO, H.; FALCI, R.; ANTONOPOULOS, I.; NAHAS, W.; PIOVESAN, A.
  • conferenceObject
    Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation.
    (2014) ANDRADE, H.; PALUELLO, D.; BATAGELLO, C.; BULL, A.; EBAID, G.; KANASHIRO, H.; FALCI, R.; ANTONOPOULOS, I.; NAHAS, W.; PIOVESAN, A.
  • conferenceObject
    PEDIATRIC KIDNEY TRANSPLANTATION: STUDYING DONOR AND RECIPIENT CHARACTERISTICS ON LONG-TERM OUTCOMES
    (2013) TORRICELLI, Fabio C. M.; MESSI, Gustavo B.; ANTONOPOULOS, Ioannis M.; PIOVESAN, Affonso C.; FALCI JR., Renato; KANASHIRO, Hideki; EBAID, Gustavo X.; SCHVARTSMAN, Benita G. S.; WATANABE, Andreia; VAISBICH, Maria H.; DAVID-NETO, Elias; NAHAS, William C.
    PURPOSE: To study donor and recipient characteristics on graft and pediatric patient survival rates. METHOD: We retrospectively reviewed 287 electronic charts of patients (under 18 year-old) underwent kidney transplantation from 01/1985 to 10/2012. Outcomes were analyzed based on the type of donor (deceased vs. living kidney donor) and recipient ESRD cause (nephrological vs. urological disease). The outcomes from recipients of deceased donors were also analyzed based on age of donors (< 17 vs. ≥ 18 years). Thereafter, the outcomes from first transplant and retransplant were compared apart. Graft and patient survival rates were compared with Kaplan-Meier curve and analyzed with Log-rank test. RESULTS: There were 309 pediatric kidney transplants in 287 children. 274 were first, 33 were second, and 2 were third grafts. 193 of 274 (67.2%) and 18 of 33 (54.5%) were living kidney transplantation. 62% of deceased donors were under 17 year-old. Regarding ESRD 195 (68%) patients presented with a nephrological cause, while 92 (32%) presented with a urological one. Of those with a urological cause, 28 (30.4%) underwent bladder augmentation. Mean follow-up was 13.7 (0–27) years. Overall, graft survival rate in one, 5 and 10 years of follow-up was 90.1%, 73.2% and 57.9%, while patient survival rate was 96.0%, 91.9% and 87.2%, respectively. There was a tendency of a higher graft survival rate in children with living kidney donors (p=0.058). There was no difference in the outcomes from first and second transplant, except by a higher immunological graft loss in retransplant group (p=0.032). There was also no difference in the graft survival rates regarding age of donor (p=0.630) and recipient ESRD cause (p=0.890). CONCLUSION: Long-term outcomes from pediatric kidney transplantation are not related to age of donor and recipient ESRD cause, since the urogenital abnormality has been corrected. Living kidney transplantation seems to present a higher graft survival rate.
  • conferenceObject
    BLADDER AUGMENTATION IN KIDNEY TRANSPLANT PATIENTS: COMPARISON BETWEEN TYPES OF LOWER URINARY RECONSTRUCTION.
    (2017) YAMACAKE, Kleiton; PIOVESAN, Affonso; FALCI, Renato; MESSI, Gustavo; ANTONOPOULOS, Ioannis; DAVID-NETO, Elias; KANASHIRO, Hideki; LOCALI, Rafael; EBAID, Gustavo; NAHAS, William
  • conferenceObject
    Transurethral Resection or Incision of the Prostate After Renal Transplantation: Is There a Safe Time for the Procedure?
    (2014) PIOVESAN, A.; ANDRADE, H.; KANASHIRO, H.; FALCI, R.; ANTONOPOULOS, I.; NAHAS, W.
  • article 5 Citação(ões) na Scopus
    C4d staining in post-reperfusion renal biopsy is not useful for the early detection of antibody-mediated rejection when CDC crossmatching is negative
    (2011) DAVID-NETO, Elias; DAVID, Daisa S. R.; GINANI, Giordano F.; RODRIGUES, Helcio; SOUZA, Patricia S.; CASTRO, Maria Cristina R.; KANASHIRO, Hideki; SAITO, Fernando; FALCI JR., Renato; ANTONOPOULOS, Ioannis M.; PIOVESAN, Afonso Celso; NAHAS, William C.
    Background. Sensitized patients (pts) may develop acute antibody-mediated rejection (AMR) due to preformed donor-specific antibodies, undetected by pre-transplant complement-dependent cytotoxicity (CDC) crossmatch (XM). We hypothesized that C4d staining in 1-h post-reperfusion biopsies (1-h Bx) could detect early complement activation in the renal allograft due to preformed donor-specific antibodies. Methods. To test this hypothesis, renal transplants (n = 229) performed between June 2005 and December 2007 were entered into a prospective study of 1-h Bx and stained for C4d by immunofluorescence. Transplants were performed against a negative T-cell CDC-XM with the exception of three cases with a positive B-cell XM. Results. All 229 1-h Bx stained negative for C4d. Fourteen pts (6%) developed AMR. None of the 14 protocol 1-h Bx stained positive for C4d in peritubular capillaries (PTC). However, all indication biopsies-that diagnosed AMR-performed at a median of 8 days after transplantation stained for C4d in PTC. Conclusions. These data show that C4d staining in 1-h Bx is, in general, not useful for the early detection of AMR when CDC-XM is negative.